LabCorp Taps Omicia to Provide Interpretation Software | GenomeWeb

NEW YORK (GenomeWeb) – Bioinformatics firm Omicia said today that Laboratory Corporation of America will use its clinical next-generation sequencing interpretation software as part of its clinical trials sequencing services offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.